logo
Share SHARE
FONT-SIZE Plus   Neg

Panasonic Renews Global Advertising Contract With Neymar Jr.

Panasonic Corp. (PC) announced that it is renewing its global advertising contract with Brazilian national soccer team and FC Barcelona player, Neymar da Silva Santos Junior. The new contract will last for four years from April 2013.

The company said that Neymar Jr. will also appear in new advertisements for the company's B2B solutions to be rolled out in 193 countries and regions, starting in Japan from July 22, 2013.

Panasonic commented that in March 2010, the company became the first Japanese company to sign an advertising contract with Neymar Jr. to appear in advertising in Brazil. In April 2011, the company and Neymar Jr. signed a two-year global contract, and Neymar Jr. became the global publicity character for the company, including its work with the London 2012 Olympic Games.

In anticipation of the Rio 2016 Olympic Games, a four-year contract from April 2013 to March 2017 has been signed, and Neymar Jr. will act as the global ambassador for the company in its B2C and B2B business promotional activities, advertising activities for the Rio 2016 Olympic Games, CSR activities, including its eco activities and activities for the development of the next generation, as well as other activities, Panasonic stated.

Panasonic said that In addition to advertising and sales-promotion campaigns for B2C businesses focused on audio-visual equipment, it will also proactively launch global advertising with Neymar Jr. for its B2B solutions businesses.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Foodservice distributor Sysco Corp. (SYY) reported a third-quarter profit that grew 22.7 percent from last year, while quarterly sales increased 2.2 percent. Both earnings per share and revenue for the quarter beat analysts' expectations. Halliburton Co. (HAL) and Baker Hughes Inc. (BHI) announced Sunday that they terminated the merger agreement they entered into in November 2014, effective April 30, 2016. In connection with the termination of the merger agreement, Halliburton will pay Baker Hughes the termination fee of $3.5 billion... The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves.
comments powered by Disqus
Follow RTT